Nuclear Medicine,or Radiopharmaceuticals, are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide. —
The Global Nuclear Medicine Market research 2018 highlights the major details and provides in-depth analysis of the market along with the future growth and prospects. The reports also offer important insights which help the industry experts, product managers, CEOs, and business executives to draft their policies on various parameters including expansion, acquisition, and new product launch as well as analyzing and understanding the market trends and demands with the help of 15 Chapters, complete report with 132 Pages, figures, graphs and table of contents to analyze the situations of global Nuclear Medicine market and Assessment to 2023. Nuclear Medicine market globally is witnessing good traction which is evident by the global Nuclear Medicine report. The report provides the customers a thorough coverage of the Nuclear Medicine industry performance over the last 5 years, and an accurate estimation of the market performance substantiated by the observed market trends over the years. Furthermore, the report covers accurate projection of the Nuclear Medicine Market for the forecast period of 2018-2023.
Get a Complete Copy of this Report @ http://www.reportsnreports.com/purchase.aspx?name=1552169
The global average price of Nuclear Medicine is in the decreasing trend, from 41.6 USD/Dose in 2011 to 39.5 USD/Dose in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Nuclear Medicine includes Tc-99, I-123/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 in 2015 is about 51.60%, and the proportion is stable from 2011 to 2015.
Nuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share in 2015 is 61.23%. The trend of Diagnostic is decreasing.
The worldwide market for Nuclear Medicine is expected to grow at a CAGR of roughly 7.6% over the next five years, will reach 6610 million US$ in 2023, from 4590 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers:
- Bracco Imaging
- Lantheus Medical Imaging
- Triad Isotopes
- Jubilant Pharma
- Eli Lilly
- China Isotope & Radiation
- Dongcheng and more
The Nuclear Medicine industry report has an in-depth coverage of the market along with multiple segmentations of the Nuclear Medicine such as by type, application, and region among others.
Market Segment by Regions, regional analysis covers: North America (USA, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Columbia, etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa).
The report further covers the detailed analysis substantiated with suitable statistics of the factors, opportunities, challenges, and prospects for the players in the Nuclear Medicine. Moreover, the report covers all the top players in the Nuclear Medicine which is inclusive of a detailed company profile, the products on offer, and revenue and market share of each player.
Market Segment by Type, covers:
Market Segment by Applications, can be divided into:
There are 15 Chapters to deeply display the Global Nuclear Medicine market.
Chapter 1: to describe Nuclear Medicine Introduction, product scope, market overview, market opportunities, market risk, market driving force, Chapter 2: to analyze the top manufacturers of Nuclear Medicine, with sales, revenue, and price of Nuclear Medicine, in 2016 and 2018
Chapter 3: to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2018, Chapter 4: to show the global market by regions, with sales, revenue and market share of Nuclear Medicine, for each region, from 2012 to 2018
Chapter 5, 6, 7, 8 and 9: to analyze the key regions, with sales, revenue and market share by key countries in these regions; Chapter 10 and 11: to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2018
Chapter 12: Nuclear Medicine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023, Chapter 13, 14 and 15: to describe Nuclear Medicine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.
List of Tables:
Global Nuclear Medicine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2018)
Global Nuclear Medicine Market Analysis by Regions
North America Nuclear Medicine by Countries
Europe Nuclear Medicine by Countries
Asia-Pacific Nuclear Medicine by Countries and more……….
Phone: +1 888 391 5441
Name: Hrishikesh Patwardhan
Email: Send Email
Phone: +1 888 391 5441
Release ID: 367795